Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America

Vandana Singh

Thu, Sep 23, 2021, 11:08 AM1 min read

In this article:

Knight Therapeutics Inc has acquired exclusive rights from Incyte Corporation (NASDAQ: INCY) to distribute tafasitamab and pemigatinib (Pemazyre) in Latin America.
Related: Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada.
Under the agreement terms, Incyte will be responsible for developing, manufacturing, and supplying tafasitamab and pemigatinib.
Knight will be responsible for seeking the necessary regulatory approvals distributing both medicines in Latin America.
Tafasitamab, in combination with lenalidomide, is approved in the U.S and Europe for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant (ASCT).
Pemigatinib is approved in the U.S., Europe, and Japan for locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
Read Next: Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD.
Price Action: INCY stock is down 0.10% at $69.52 during the market session on the last check Thursday.

See more from Benzinga

1 Ridiculously Undervalued Growth Stock Down 93% to Buy Hand Over Fist Right Now in May
Investors are not convinced that this cheap stock is safe from the rising effectiveness of artificial intelligence.
Motley Fool
'Which Bucket Do I Draw From First?' Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts
When Ellen, a 67-year-old retiree, reached out to Suze Orman during her podcast, she had a straightforward yet crucial financial inquiry: "Which bucket do I draw from first?" Ellen, whose Social Security covers most of her daily living expenses, needed guidance on how to use her different types of retirement accounts for additional expenditures like travel. Don't Miss: The recommended retirement savings amount is $550K, but here is why so many Americans are falling short. Reddit user reveals his
Benzinga
Analysts overhaul Nvidia stock price targets ahead of earnings
The chipmaker's new GB200 platform could transform its medium-term revenue growth, according to Wall Street analysts.
TheStreet
The stock market is about to see a 10% correction, with further disinflation a 'pipe dream' and Fed rate cuts coming much later, Stifel says
Inflation falling further from here in the near term is a "pipe dream" and rate cuts will continue to be pushed out, Stifel strategists said.
Business Insider
Can You Guess How Many Retire With A $5 Million Nest Egg?
In the realm of retirement savings, only a select few in the United States achieve the milestone of a $5 million nest egg. Data from the Employee Benefit Research Institute, based on the Federal Reserve’s Survey of Consumer Finances, reveals that a mere 0.1% of retirees manage to accumulate over $5 million in their retirement accounts, whereas only 3.2% amass over $1 million. Don't Miss: 82% of Americans aren’t using this government secured 5% passive income stream, are you one of them? Can you
Benzinga
A Bull Market Is Here: 2 Artificial Intelligence Stocks Down 27% and 60% to Buy Right Now
Buying these beaten-down chip stocks could help you profit from the AI revolution.
Motley Fool
Two Utility Stocks Outperform Nvidia — Even Before Adding Dividends
Nvidia stock investors have a trillion reasons to celebrate. But shockingly owners of two S&P 500 utility stocks have done even better this year.
Investor's Business Daily
3 High-Yield Dividend Stocks to Buy Hand Over Fist in May
Who said high-yield dividend stocks are too risky?
Motley Fool
Wall Street Desks Warn CPI Report May Upset Stock-Market Calm
(Bloomberg) -- From JPMorgan Chase & Co. to Citigroup Inc., Wall Street’s most prominent trading desks are warning that investors should gear up for a potential break in the calm that’s come over the market.Most Read from BloombergTrump Vows ‘Day One’ Executive Order Targeting Offshore WindGameStop Shares Soar as ‘Roaring Kitty’ Revitalizes Retail FrenzyTesla Rehires Some Supercharger Workers Weeks After Musk’s CutsChina to Start $138 Billion Bond Sale on Friday to Boost EconomyMacron Puts Frenc
Bloomberg
From a melt-up to a sell-off, the next 2 weeks will determine the stock market's direction for the summer
"Inflation and NVIDIA earnings data that exceed expectations could set the stage for an early summer melt-up," UBS said.
Business Insider

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America

Recommended Stories

1 Ridiculously Undervalued Growth Stock Down 93% to Buy Hand Over Fist Right Now in May

'Which Bucket Do I Draw From First?' Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts

Analysts overhaul Nvidia stock price targets ahead of earnings

The stock market is about to see a 10% correction, with further disinflation a 'pipe dream' and Fed rate cuts coming much later, Stifel says

Can You Guess How Many Retire With A $5 Million Nest Egg?

A Bull Market Is Here: 2 Artificial Intelligence Stocks Down 27% and 60% to Buy Right Now

Two Utility Stocks Outperform Nvidia — Even Before Adding Dividends

3 High-Yield Dividend Stocks to Buy Hand Over Fist in May

Wall Street Desks Warn CPI Report May Upset Stock-Market Calm

From a melt-up to a sell-off, the next 2 weeks will determine the stock market's direction for the summer